Testing effectiveness (Phase 2)Looking for participantsNCT07617246
What this trial is testing
The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer
Who this might be right for
Esophagus CancerLung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 120